Datum: 2.4.2008
The unique study of UCS biologists proposes a new paradigm in cancer treatment: Instead of selectively attacking cancer cells, protect all other cells against chemotherapy.
Making chemotherapy more selective has been a top cancer research goal for decades. Now, the animal studies and in vitro human cell studies show that a two days fast protects healthy cells against chemotherapy, while tumor cells remain sensitive to the drugs. Mice given a high dose of chemotherapy after fasting continued to thrive. The same dose killed half the normally fed mice and caused lasting weight and energy loss in the survivors.
"In theory, it opens up new treatment approaches that will allow higher doses of chemotherapy. It's a direction that's worth pursuing in clinical trials in humans," say the researchers at University of Southern California. Fasting before chemotherapy has still unknown risks and benefits for humans. The effectiveness and safety of the method will be established by future clinical trials.
Source: http://www.usc.edu
FEBS Congress 2009
Prague, Czech Republic, July 05, 2009
Kosmetologie a nanomedicína
aneb kosmetologie není kosmetika a nanomedicína neléčí trpaslíky
Brno, Czech Republic, August 24, 2009
XXXIXth Annual Meeting of the European Society for New Methods in Agricultural Research
Brno, Czech Republic, August 25-29, 2009
Biotrans 2009
Kultur-Casino Bern, Bern, Switzerland, July 05-09, 2009
Biomechanical Design of Nanotechnological Devices for Health Care
Udine, Italy, July 06-10, 2009
International Conference on Fungal Evolution and Charles Darwin: Fom Morphology to Molecules
Pathumthani, Thailand, July 09-11, 2009
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Biotech events - Interesting events in biotech segment
Brno University of Technology - university of technology in Brno
Melon research sweetened with DNA sequence
Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies